CTLA4 and neoplasm: developed an injectable PEG-b-poly(L-alanine) (PEA) hydrogel to co-deliver a tumor vaccine consisting of tumor cell lysates (TCLs), granulocyte-macrophage colony-stimulating factor (GM-CSF), and anti-CTLA-4 antibodies and anti-PD-1 antibodies (60).